Hamilos George
October 21, 2025 2025-10-21 8:52Hamilos George
Hamilos George
Associate Professor of Clinical Microbiology - Microbial Pathogenesis
Medical School, University of Crete, P.C. 70013 Heraklion, Crete
Giorgos Chamilos is a Professor and Head of the Laboratory of Clinical Microbiology and Microbial Pathogenesis at the Medical School, University of Crete (research group website: https://cmmp.med.uoc.gr) since March 2016, and an Affiliated Researcher at the FORTH/IMBB since February 2018.
Dr. Chamilos has been an attending physician in Internal Medicine with a focus on infectious diseases at the University Hospital of Heraklion (PAGNI) and affiliated researcher with the University of Crete (2009–2016).
Dr. Chamilos’ research group (06/2009) focuses on research in the immunology and pathogenesis of invasive fungal diseases and the mechanisms of immune deactivation in sepsis. The group employs innovative assays, ex vivo models of infection in human phagocytes, and in vivo infection models in transgenic mice and Drosophila melanogaster. Current research activities focus on elucidating the molecular mechanisms of intracellular and extracellular inhibition of pathogenic fungal growth, with an emphasis on the role of autophagy in regulating phagosome maturation.
2009-2011 Postdoctoral fellow, Department of Immunology, School of Medicine, University of Crete
2007-2009 Postdoctoral fellow, Infectious Diseases/Immunology, The University of Texas Health Science Center at Houston Medical School, Houston, TX
2008-2009 Clinical Fellowship in Infectious Disease, The University of Texas Health Science Center at Houston Medical School, Houston, TX
2003-2007 PhD, Department of Therapeutics, Medical School, University of Athens, Greece, and the MDACC, Houston, TX, Prof. DP. Kontoyiannis Lab 2004-2006)
1998-2003 Residency in Internal Medicine, Department of Therapeutics, Medical School, University of Athens, Greece
1997-1998 Internship in Internal Medicine, Ierapetra General Hospital, Crete, Greece
1990-1996 School of Medicine, National and Kapodistrian University of Athens, Greece, Medical Diploma (MD)
Our research has two main directions:
- a basic science path aiming to understand mechanisms of host-fungal interplay with emphasis on molecular interactions in the phagosome
- a translational path that explores mechanisms of immune dysfunction leading to development of IMI and immunomodulatory strategies aiming to restore phagocyte defects in patients at high risk for IMI.
To achieve our goals in part (i) of our research we utilize:
- Multi-omics approaches in primary immune cells and isolated phagosomes to identify novel antifungal effector pathways and their regulation by cell metabolism
- In vivo genetic screens in Drosophila melanogaster RNAi strains to identify evolutionarily conserved antifungal host defense mechanisms in phagocytes
- Advanced bioimaging tools, molecular and biochemical approaches to functionally validate the physiological importance of novel host effectors
- Transgenic mice to explore the role of identified host pathways and pathogen effectors in physiological antifungal immunity and disease pathogenesis.
To achieve our goals in part (ii) of our research we participate in International Collaborative Networks (TRANS-CPA and HDM-FUN) aiming to understand
pathogenesis and mechanisms of response to immunotherapy in patients with IMI. In parallel, we perform prospective biobanking of clinical samples from
immunocompromised patients of interest and maintain an expanding collection of tissue biopsies from patients with IMI diagnosed at the University Hospital of
Heraklion, Crete. Ongoing clinical protocols allow for assessment of the immunomodulatory activity of clinically-approved compounds on phagosome
biogenesis and macrophage immunometabolism. Finally, in order to dissect interesting immune phenotypes identified in human studies, we perform
mechanistic studies in physiologically relevant mouse models of IMI.
Selected Publications:
1. Pikoulas A, Morianos I, Nidris VN, Hamdy R, López-López A, Moran-Garrido M, Muthu V, Halabalaki M, Papadovasilaki M, Irene K, Gu Y, Aerts R, Mercier T, Vanbiervliet Y, Cho SY, Spallone A, Samonakis D, Kastritis E, Drakos E, Tzardi M, Eliopoulos A, Georgila K, Carvalho A, Kurzai O, Rudramurthy S, Lanternier F, Petratos K, Maertens J, Bruno V, Kontoyiannis D, Barbas C, Soliman S, Ibrahim A, Chamilos G*. Albumin orchestrates a natural host defense mechanism against mucormycosis. Res Sq [Preprint]. 2024 Dec 3:rs.3.rs-5441197. doi: 10.21203/rs.3.rs-5441197/v1. * Corresponding author
2. Seldeslachts L, Staels F, Gkountzinopoulou M, Jacobs C, Tielemans B, Vanhoffelen E, Reséndiz-Sharpe A, De Herdt L, Haughton J, Prezzemolo T, Burton O, Feys S, van de Veerdonk FL, Carvalho A, Naesens L, Matthys P, Lagrou K, Verbeken E, Chamilos G, Wauters J, Humblet-Baron S, Vande Velde G. Damping excessive viral-induced IFN-γ rescues the impaired anti-Aspergillus host immune response in influenza-associated pulmonary aspergillosis. EBioMedicine. 2024 Oct;108:105347. doi: 10.1016/j.ebiom.2024.105347.
3. Akoumianaki T, Vaporidi K, Diamantaki E, Pène F, Beau R, Gresnigt MS, Gkountzinopulou M, Venichaki M, Drakos E, El-Benna J, Samonis G, Le KTT, Kumar V, Georgopoulos D, van de Veerdonk FL, Netea MG, Latge JP, Chamilos G*. Uncoupling of IL-6 signaling and LC3-associated phagocytosis drives immunoparalysis during sepsis. Cell Host Microbe. 2021 Aug 11;29(8):1277-1293.e6. doi: 10.1016/j.chom.2021.06.002.* Corresponding author
4. Soliman SSM, Baldin C, Gu Y, Singh S, Gebremariam T, Swidergall M, Alqarihi A, Youssef EG, Alkhazraji S, Pikoulas A, Perske C, Venkataramani V, Rich A, Bruno VM, Hotopp JD, Mantis NJ, Edwards JE Jr, Filler SG, Chamilos G, Vitetta ES, Ibrahim AS. Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis. Nat Microbiol. 2021 Mar;6(3):313-326. doi: 10.1038/s41564-020-00837-0.
5. Andrianaki AM, Kyrmizi I, Thanopoulou K, Baldin C, Drakos E, Soliman SSM, Shetty AC, McCracken C, Akoumianaki T, Stylianou K, Ioannou P, Pontikoglou C, Papadaki HA, Tzardi M, Belle V, Etienne E, Beauvais A, Samonis G, Kontoyiannis DP, Andreakos E, Bruno VM, Ibrahim AS, Chamilos G*. Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species. Nat Commun. 2018 Aug 20;9(1):3333. doi: 10.1038/s41467-018-05820-2.* Corresponding author
6. Kyrmizi I, Ferreira H, Carvalho A, Figueroa JAL, Zarmpas P, Cunha C, Akoumianaki T, Stylianou K, Deepe GS Jr, Samonis G, Lacerda JF, Campos A Jr, Kontoyiannis DP, Mihalopoulos N, Kwon-Chung KJ, El-Benna J, Valsecchi I, Beauvais A, Brakhage AA, Neves NM, Latge JP, Chamilos G*. Calcium sequestration by fungal melanin inhibits calcium-calmodulin signalling to prevent LC3-associated phagocytosis. Nat Microbiol. 2018 Jul;3(7):791-803. doi: 10.1038/s41564-018-0167-x. * Corresponding author
7. Akoumianaki T, Kyrmizi I, Valsecchi I, Gresnigt MS, Samonis G, Drakos E, Boumpas D, Muszkieta L, Prevost MC, Kontoyiannis DP, Chavakis T, Netea MG, van de Veerdonk FL, Brakhage AA, El-Benna J, Beauvais A, Latge JP, Chamilos G*. Aspergillus Cell Wall Melanin Blocks LC3-Associated Phagocytosis to Promote Pathogenicity. Cell Host Microbe. 2016 Jan 13;19(1):79-90. doi: 10.1016/j.chom.2015.12.002. * Corresponding author
8. Kyrmizi I, Gresnigt MS, Akoumianaki T, Samonis G, Sidiropoulos P, Boumpas D, Netea MG, van de Veerdonk FL, Kontoyiannis DP, Chamilos G*. Corticosteroids block autophagy protein recruitment in Aspergillus fumigatus phagosomes via targeting dectin-1/Syk kinase signaling. J Immunol. 2013 Aug 1;191(3):1287-99. doi: 10.4049/jimmunol.1300132. * Corresponding author
9. Chamilos G, Gregorio J, Meller S, Lande R, Kontoyiannis DP, Modlin RL, Gilliet M. Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37. Blood. 2012 Nov 1;120(18):3699-707. doi: 10.1182/blood-2012-01-401364.
10. Chamilos G, Lewis RE, Hu J, Xiao L, Zal T, Gilliet M, Halder G, Kontoyiannis DP. Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9367-72. doi: 10.1073/pnas.0709578105.
Selected
2015 Greek Government, Research Programs for Excellence IKY/Siemens (2894)
2014 Greek Government, General Secretary for Research and Technology (525171)
2010 Postdoctoral Marie Curie Reintegration fellowship, (260210)
2007 The Kimberly Patterson Fellowship in Leukemia Research award, The University of Texas M. D. Anderson Cancer Center (2007)
